Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties

Bioorganic & Medicinal Chemistry Letters
1999.0

Abstract

Sulfonylamido(ureido) derivatives of histamine were synthesized by an original procedure in order to obtain tight-binding activators of the zinc enzyme carbonic anhydrase (CA), exploiting the binding energy of the alkyl/arylsulfonyl moieties with amino acid residues at the entrance of the active site. In contrast to the lead molecule, histamine, the new derivatives possessed higher affinity for three different CA isozymes, as evidenced by compairing the affinity constants of these compounds for isozyme CA II.

Knowledge Graph

Similar Paper

Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties
Bioorganic & Medicinal Chemistry Letters 1999.0
Carbonic anhydrase activators: Activation of human isozymes I, II and IX with phenylsulfonylhydrazido l-histidine derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
Carbonic anhydrase I and II activation with mono- and dihalogenated histamine derivatives
Bioorganic & Medicinal Chemistry Letters 2011.0
Carbonic Anhydrase Activators:  High Affinity Isozymes I, II, and IV Activators, Incorporating a β-Alanyl-histidine Scaffold
Journal of Medicinal Chemistry 2002.0
Mono- and di-halogenated histamine, histidine and carnosine derivatives are potent carbonic anhydrase I, II, VII, XII and XIV activators
Bioorganic & Medicinal Chemistry 2014.0
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide
Bioorganic & Medicinal Chemistry Letters 2004.0
Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with l-histidine as a platform for the design of stronger activators
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII
Bioorganic & Medicinal Chemistry 2016.0
Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties
Bioorganic & Medicinal Chemistry Letters 2007.0